Literature DB >> 19224156

Throat infection, neck and chest pain and cardiac response: a persistent infection-related clinical syndrome.

Changqing Zhou1, Xiangning Fu, Jiangtao Yan, Qiao Fan, Zhuoya Li, Katherine Cianflone, Daowen Wang.   

Abstract

Dizziness, chest discomfort, chest depression and dyspnea are a group of symptoms that are common complaints in clinical practice. Patients with these symptoms are usually informed that while neurosis consequent to coronary heart disease is excluded nonetheless they remain unhealthy with no rational explanation or treatment. 165 cases of these symptoms and 85 control subjects were reviewed and underwent further medical history inquiry, routine EKG test and cardiac ultrasound examination. Thirty-five patients received coronary artery angiography to exclude coronary heart disease. Serum myocardial autoantibodies against beta(1)-adrenoceptor, alpha-myosin heavy chain, M(2)-muscarinic receptor and adenine-nucleotide translocator were tested, and inflammatory cytokines and high sensitivity C-reaction protein were measured and lymphocyte subclass was assayed by flow cytometry. All patients had a complex of four symptoms or tetralogy: (1) persistent throat or upper respiratory tract infection, (2) neck pain, (3) chest pain and (4) chest depression or dyspnea, some of them with anxiety. Anti-myocardial autoantibodies (AMCAs) were present in all patients vs. 8% in controls. TNF-alpha, IL-1 and IL-6 were significantly higher in patients than in controls (P<0.01). CD3(+) and CD4-CD8(+) lymphocytes were significantly higher and CD56(+) lymphocytes lower in patients than those in controls (P<0.01). The ratio of serum pathogen antibodies positive against Coxsackie virus-B, cytomegalovirus, Mycoplasma pneumoniae and Chlamydia pneumoniae were all markedly higher in patients. These data led to identification of a persistent respiratory infection-related clinical syndrome, including persistent throat infection, neck spinal lesion, rib cartilage inflammation, symptoms of cardiac depression and dyspnea with or without anxiety.

Entities:  

Mesh:

Year:  2009        PMID: 19224156     DOI: 10.1007/s11596-009-0104-6

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  22 in total

1.  Characterization of anti-myocardial autoantibodies in Japanese patients with dilated cardiomyopathy.

Authors:  A Baba; T Yoshikawa; M Chino; A Murayama; K Mitani; S Nakagawa; I Fujii; M Shimada; M Akaishi; S Iwanaga; Y Asakura; K Fukuda; H Mitamura; S Ogawa
Journal:  Jpn Circ J       Date:  2001-10

2.  Mapping of antigenic determinants of the adenine-nucleotide translocator and coxsackie B3 virus with synthetic peptides: use for the diagnosis of viral heart disease.

Authors:  P L Schwimmbeck; N K Schwimmbeck; H P Schultheiss; B E Strauer
Journal:  Clin Immunol Immunopathol       Date:  1993-08

3.  Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits.

Authors:  S Matsui; M L Fu; S Katsuda; M Hayase; N Yamaguchi; K Teraoka; T Kurihara; N Takekoshi; E Murakami; J Hoebeke; A Hjalmarson
Journal:  J Mol Cell Cardiol       Date:  1997-02       Impact factor: 5.000

4.  The possible value of synthetic peptides in the diagnosis and therapy of myocarditis and dilated cardiomyopathy.

Authors:  P L Schwimmbeck; N K Bland; H P Schultheiss; B E Strauer
Journal:  Eur Heart J       Date:  1991-08       Impact factor: 29.983

5.  Treatment of noncardiac chest pain of psychological origin.

Authors:  Kevin W Olden
Journal:  Curr Treat Options Gastroenterol       Date:  2006-02

6.  Evaluation of a clinical decision rule for young adult patients with chest pain.

Authors:  Robert J Marsan; Kyle J Shaver; Keara L Sease; Frances S Shofer; Frank D Sites; Judd E Hollander
Journal:  Acad Emerg Med       Date:  2005-01       Impact factor: 3.451

Review 7.  Evaluation of the emergency department chest pain patient.

Authors:  M C Kontos; R L Jesse
Journal:  Am J Cardiol       Date:  2000-03-09       Impact factor: 2.778

8.  Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.

Authors:  L X Fu; Y Magnusson; C H Bergh; J A Liljeqvist; F Waagstein; A Hjalmarson; J Hoebeke
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

9.  Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathies but not with hypertension.

Authors:  M L Fu; J Hoebeke; S Matsui; M Matoba; Y Magnusson; T Hedner; H Herlitz; A Hjalmarson
Journal:  Clin Immunol Immunopathol       Date:  1994-07

10.  Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure.

Authors:  Arne Yndestad; Are M Holm; Fredrik Müller; Svein Simonsen; Stig S Frøland; Lars Gullestad; Pål Aukrust
Journal:  Cardiovasc Res       Date:  2003-10-15       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.